论文部分内容阅读
目的:探讨远端胃间置术治疗不可切除性远端胃癌的临床疗效。方法:对6例远端晚期胃癌并幽门梗阻、原发肿瘤已不能切除的患者进行远端胃间置术联合近端胃空肠BillrothⅡ吻合(3例)和Roux-en-Y吻合(3例)。结果:所有患者在术后3~5 d肛门排气,平均(3.8±1.0)d;3~10 d恢复进食,平均(5.5±2.6)d;术后2个月较术前血清白蛋白增加3.9~11.4 g/L,平均(6.5±2.7)g/L;体重增加0.8~3.3 kg,平均(2.3±1.0)kg;术后生存3~22个月,平均(11.8±8.1)个月。结论:远端胃间置术可明显改善不可切除性远端胃癌患者的全身情况、提高生活质量、延长生存时间,是治疗不可切除性远端胃癌的一种有效方法,值得临床推广应用。
Objective: To investigate the clinical effect of distal gastrostomy in the treatment of unresectable distal gastric cancer. Methods: 6 cases of distal advanced gastric cancer with pyloric obstruction and primary tumor who had been unresectable were treated with distal gastrostomy combined with proximal gastrointestinal jejunal Billroth Ⅱ anastomosis (3 cases) and Roux-en-Y anastomosis (3 cases) . Results: All patients underwent anal exhaust 3 to 5 days after operation, with an average of (3.8 ± 1.0) d, and recovered from 3 to 10 days with an average of (5.5 ± 2.6) days. Serum albumin The mean survival time was 3.9 to 11.4 g / L with an average of (6.5 ± 2.7) g / L and body weight gain was 0.8 to 3.3 kg (mean, 2.3 ± 1.0) kg. The average survival time was 3 to 22 months (mean, 11.8 ± 8.1) months. Conclusion: The distal gastric surgery can significantly improve the overall condition of patients with unresectable distal gastric cancer, improve the quality of life and prolong the survival time. It is an effective method for the treatment of unresectable distal gastric cancer and is worthy of clinical application.